NO983580L - 5<alfa>-reduktaseinhibitorpreparat for oral administrering, fremgangsmÕte for fremstilling derav og anvendelse derav - Google Patents
5<alfa>-reduktaseinhibitorpreparat for oral administrering, fremgangsmÕte for fremstilling derav og anvendelse deravInfo
- Publication number
- NO983580L NO983580L NO983580A NO983580A NO983580L NO 983580 L NO983580 L NO 983580L NO 983580 A NO983580 A NO 983580A NO 983580 A NO983580 A NO 983580A NO 983580 L NO983580 L NO 983580L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- alpha
- oral administration
- reductase inhibitor
- formulation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1871896 | 1996-02-05 | ||
| PCT/JP1997/000273 WO1997027875A1 (fr) | 1996-02-05 | 1997-02-04 | PREPARATION INHIBITRICE DE LA 5α-REDUCTASE ADMINISTRABLE PAR VOIE ORALE, PROCEDE DE PRODUCTION ET UTILISATION |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO983580D0 NO983580D0 (no) | 1998-08-04 |
| NO983580L true NO983580L (no) | 1998-10-02 |
Family
ID=11979447
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO983580A NO983580L (no) | 1996-02-05 | 1998-08-04 | 5<alfa>-reduktaseinhibitorpreparat for oral administrering, fremgangsmÕte for fremstilling derav og anvendelse derav |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20020015732A1 (no) |
| EP (1) | EP0923942B1 (no) |
| KR (1) | KR19990082277A (no) |
| CN (1) | CN1215339A (no) |
| AT (1) | ATE208631T1 (no) |
| AU (1) | AU709146B2 (no) |
| CZ (1) | CZ289856B6 (no) |
| DE (1) | DE69708307T2 (no) |
| DK (1) | DK0923942T3 (no) |
| ES (1) | ES2165017T3 (no) |
| HK (1) | HK1020258A1 (no) |
| HU (1) | HUP9901870A3 (no) |
| MX (1) | MX9806292A (no) |
| NO (1) | NO983580L (no) |
| NZ (1) | NZ326897A (no) |
| PT (1) | PT923942E (no) |
| RU (1) | RU2154467C2 (no) |
| WO (1) | WO1997027875A1 (no) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL335365A1 (en) * | 1997-02-26 | 2000-04-25 | Sankyo Co | Composition for treating or preventing prostatic carcinoma |
| AU733830B2 (en) * | 1997-07-29 | 2001-05-24 | Sankyo Company Limited | Remedial agent for baldness and other diseases |
| CN110628735B (zh) * | 2019-04-23 | 2022-04-08 | 天津科技大学 | 一种5α-还原酶突变体，基因工程菌及其在高效催化5α-AD生产中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8403359D0 (en) * | 1984-02-08 | 1984-03-14 | Erba Farmitalia | Pharmaceutical compositions |
| ZA851426B (en) * | 1984-02-27 | 1986-10-29 | Merck & Co Inc | 17 beta-n-monosubstituted carbamoyl-4-aza-5 alpha-androst-1-en-3-ones as 5 alpha reductase inhibitors |
| IE76452B1 (en) * | 1990-10-29 | 1997-10-22 | Sankyo Co | Azasteroid compounds for the treatment of prostatic hypertrophy their preparation and use |
| JPH06293793A (ja) * | 1993-02-10 | 1994-10-21 | Sankyo Co Ltd | ステロイド−１７−アミド類の製造法 |
-
1997
- 1997-02-04 AU AU15589/97A patent/AU709146B2/en not_active Ceased
- 1997-02-04 HU HU9901870A patent/HUP9901870A3/hu unknown
- 1997-02-04 DE DE69708307T patent/DE69708307T2/de not_active Expired - Fee Related
- 1997-02-04 WO PCT/JP1997/000273 patent/WO1997027875A1/ja not_active Application Discontinuation
- 1997-02-04 CN CN97193555A patent/CN1215339A/zh active Pending
- 1997-02-04 RU RU98114489/14A patent/RU2154467C2/ru not_active IP Right Cessation
- 1997-02-04 PT PT97901835T patent/PT923942E/pt unknown
- 1997-02-04 ES ES97901835T patent/ES2165017T3/es not_active Expired - Lifetime
- 1997-02-04 DK DK97901835T patent/DK0923942T3/da active
- 1997-02-04 AT AT97901835T patent/ATE208631T1/de not_active IP Right Cessation
- 1997-02-04 EP EP97901835A patent/EP0923942B1/en not_active Expired - Lifetime
- 1997-02-04 KR KR1019980706006A patent/KR19990082277A/ko not_active Application Discontinuation
- 1997-02-04 CZ CZ19982342A patent/CZ289856B6/cs not_active IP Right Cessation
- 1997-02-04 NZ NZ326897A patent/NZ326897A/xx unknown
-
1998
- 1998-08-04 US US09/128,861 patent/US20020015732A1/en not_active Abandoned
- 1998-08-04 MX MX9806292A patent/MX9806292A/es unknown
- 1998-08-04 NO NO983580A patent/NO983580L/no not_active Application Discontinuation
-
1999
- 1999-11-22 HK HK99105393A patent/HK1020258A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CZ289856B6 (cs) | 2002-04-17 |
| PT923942E (pt) | 2002-03-28 |
| NZ326897A (en) | 1999-08-30 |
| WO1997027875A1 (fr) | 1997-08-07 |
| US20020015732A1 (en) | 2002-02-07 |
| AU709146B2 (en) | 1999-08-19 |
| DE69708307T2 (de) | 2002-08-14 |
| ATE208631T1 (de) | 2001-11-15 |
| MX9806292A (es) | 1998-11-30 |
| HUP9901870A3 (en) | 1999-11-29 |
| RU2154467C2 (ru) | 2000-08-20 |
| EP0923942B1 (en) | 2001-11-14 |
| EP0923942A4 (no) | 1999-06-23 |
| DE69708307D1 (de) | 2001-12-20 |
| CN1215339A (zh) | 1999-04-28 |
| DK0923942T3 (da) | 2001-12-17 |
| NO983580D0 (no) | 1998-08-04 |
| ES2165017T3 (es) | 2002-03-01 |
| EP0923942A1 (en) | 1999-06-23 |
| HUP9901870A2 (hu) | 1999-09-28 |
| AU1558997A (en) | 1997-08-22 |
| HK1020258A1 (en) | 2000-04-07 |
| CZ234298A3 (cs) | 1998-11-11 |
| KR19990082277A (ko) | 1999-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1110542T3 (da) | Oral metoprololdoseringsform til anvendelse én gang om dagen | |
| AU2002316811A1 (en) | Stable formulation of modified glp-1 | |
| BR0210078A (pt) | Composto, uso do mesmo, e, formulação farmacêutica | |
| GB2341801B (en) | Formulation | |
| DK0700284T3 (da) | Oxybutyninformuleringer med kontrolleret frigivelse | |
| EP0931788A3 (en) | Metalloprotease inhibitors | |
| TR200302214T4 (tr) | Psoriasis tedavisi için kullanilan pteridine bileşkenleri | |
| HUP9802999A2 (hu) | N-propargil-1-amino-indánt tartalmazó gyógyszerkészítmény | |
| DE59000750D1 (de) | Arzneimittel, enthaltend di-tert.-butylhydroxyphenyl-derivate sowie neue derivate. | |
| MY118828A (en) | Substituted amino compounds and their use as substances having an analgesic effect | |
| DE60042972D1 (de) | Trimetazidine enthaltendes Arzneimittel mit verzögerter Wirkstoffabgabe und Verfahren zur Herstellung | |
| ATE169637T1 (de) | Derivate des dolastatin | |
| AU2001252225A1 (en) | Oral composition comprising chlorhexinine and maltitol or erythritol or a mixture thereof | |
| NO983580L (no) | 5<alfa>-reduktaseinhibitorpreparat for oral administrering, fremgangsmÕte for fremstilling derav og anvendelse derav | |
| MY127474A (en) | Naphthyl compounds, intermediates, compositions, and methods of use | |
| YU10599A (sh) | Amorfni benzotiofeni, postupak dobijanja istih i njihova farmaceutska formulacija | |
| EA200000112A1 (ru) | Новая композиция | |
| UY24780A1 (es) | Composiciones farmacéuticas estabilizadas a base de quinupristina y dalfopristina y su preparación. | |
| DK0835656T3 (da) | Kombinationspræparat indeholdende tramadol og en calciumkanalantagonist | |
| AR008474A1 (es) | Derivado de 9-dihidroeritromicina a 6,9; 11,12-diciclocarbonato, composicion farmaceutica y preparacion bactericida que lo contienen y su uso | |
| ES2136443T3 (es) | Limpieza in situ. | |
| IT1305299B1 (it) | Composizioni farmaceutiche a lento rilascio contenenti nifedipina,metodo per la preparazione delle stesse e relativo uso. | |
| DK1105388T3 (da) | N-substituerede azabicycloheptan-derivater, fremstilling og anvendelse heraf |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |